FindTrial
Sign In

A comparative study of vaginal hyoscine butyl bromide and misoprostol on cervical ripening for gynecological intrauterine procedures

A comparative study of vaginal hyoscine butyl bromide and misoprostol on cervical ripening for gynecological intrauterine procedures

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20151228025732N68
Enrollment
50
Registered
2021-05-25
Start date
2021-05-05
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine interventions. Encounter for gynecological examination

Interventions

Intervention 1: Intervention group: Hyoscine butylbromide oral tablet (40 mg dose) is inserted vaginally into the posterior cervical region 2 hours before the intervention. Intervention 2: Control gro

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Age 18 to 55 years Before menopause

Exclusion criteria

Exclusion criteria: Pregnancy History of more than 3 deliveries Anatomic abnormalities in the genital tract Infection or wound visible in the cervix or vagina

Design outcomes

Primary

MeasureTime frame
Cervical diameter. Timepoint: Before and after the intervention. Method of measurement: The largest size of Hegar dilator that can be inserted without resistance and easily.;The amount of pain. Timepoint: Before and after the intervention. Method of measurement: Visual analogue scale for pain (0 to10).;Bleeding rate. Timepoint: Before and after the intervention. Method of measurement: Cylindrical (cc).—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShahrzad Aghaamoo

Semnan University of Medical Sciences

are20935@gmail.com+98 23 3345 1336

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026